243 related articles for article (PubMed ID: 15320765)
1. Oncogene suppression by small interfering RNAs.
Heidenreich O
Curr Pharm Biotechnol; 2004 Aug; 5(4):349-54. PubMed ID: 15320765
[TBL] [Abstract][Full Text] [Related]
2. Recent applications of RNAi in mammalian systems.
Scherer L; Rossi JJ
Curr Pharm Biotechnol; 2004 Aug; 5(4):355-60. PubMed ID: 15320766
[TBL] [Abstract][Full Text] [Related]
3. RNA-based drugs: from RNA interference to short interfering RNAs.
Poliseno L; Mercatanti A; Citti L; Rainaldi G
Curr Pharm Biotechnol; 2004 Aug; 5(4):361-8. PubMed ID: 15320767
[TBL] [Abstract][Full Text] [Related]
4. RNA interference in cancer.
Gartel AL; Kandel ES
Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
[TBL] [Abstract][Full Text] [Related]
5. Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy.
Yan R; Hallam A; Stockley PG; Boyes J
Biochem J; 2014 Jul; 461(1):1-13. PubMed ID: 24927119
[TBL] [Abstract][Full Text] [Related]
6. Better blocker: RNA interference dazzles research community.
Garber K
J Natl Cancer Inst; 2003 Apr; 95(7):500-2. PubMed ID: 12671010
[No Abstract] [Full Text] [Related]
7. Small interfering RNA-based molecular therapy of cancers.
Guo W; Chen W; Yu W; Huang W; Deng W
Chin J Cancer; 2013 Sep; 32(9):488-93. PubMed ID: 23327796
[TBL] [Abstract][Full Text] [Related]
8. Noncoding RNA for Cancer Gene Therapy.
Zhong X; Zhang D; Xiong M; Zhang L
Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic microRNA strategies in human cancer.
Li C; Feng Y; Coukos G; Zhang L
AAPS J; 2009 Dec; 11(4):747-57. PubMed ID: 19876744
[TBL] [Abstract][Full Text] [Related]
10. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
Dykxhoorn DM; Lieberman J
Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
[TBL] [Abstract][Full Text] [Related]
11. Target selectivity in mRNA silencing.
Aronin N
Gene Ther; 2006 Mar; 13(6):509-16. PubMed ID: 16520821
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications.
Huang C; Li M; Chen C; Yao Q
Expert Opin Ther Targets; 2008 May; 12(5):637-45. PubMed ID: 18410245
[TBL] [Abstract][Full Text] [Related]
13. Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy.
Senapati D; Patra BC; Kar A; Chini DS; Ghosh S; Patra S; Bhattacharya M
Gene; 2019 Nov; 719():144071. PubMed ID: 31454539
[TBL] [Abstract][Full Text] [Related]
14. RNA interference as a potential tool in the treatment of leukaemia.
Borkhardt A; Heidenreich O
Expert Opin Biol Ther; 2004 Dec; 4(12):1921-9. PubMed ID: 15571454
[TBL] [Abstract][Full Text] [Related]
15. Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing.
Chakraborty C
Curr Drug Targets; 2007 Mar; 8(3):469-82. PubMed ID: 17348839
[TBL] [Abstract][Full Text] [Related]
16. [RNA interference (RNAi) and its therapeutic potential in cancer].
Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
[TBL] [Abstract][Full Text] [Related]
17. [Application of RNAi to cancer therapy].
Tan YL; Yin JQ
Yao Xue Xue Bao; 2005 Mar; 40(3):193-8. PubMed ID: 15952587
[No Abstract] [Full Text] [Related]
18. Research tool with therapeutic potential.
Lederman L
Biotechniques; 2007 Aug; 43(2):155, 157, 159. PubMed ID: 17824382
[No Abstract] [Full Text] [Related]
19. [Advances in research on RNA interference-related drugs for cancer treatment].
Ren HW; Yang BX
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):801-4. PubMed ID: 23291125
[No Abstract] [Full Text] [Related]
20. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
